Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
AXDX - well it seems major news on MRSA's... New antibiotics... And AXDX presentations muted my recent projections of a deeper bottom... Oh well... I love this company... Management... And technology... So maybe bottoms will be shallower in 2015 than previous years... As AXDX gets closer to bringing technology to market... But the upside on this stock is HUGE... It is a good stock to be ULTRALONG!!!
Wow, thanks for your efforts to provide such detail.
I am fortunate to have been a shareholder prior to the current management buyout and I am looking to take another bite around $16 or less. Short interest is high, so there will be more downside, I hope. Thanks, again.
AXDX - mmillionaire - spoke with management everything is still in progress and on target for early Q2 2016 for monetization of the diagnostic technology... additional interest from CDC and other entities related to the diagnostic technology as it pertains to MRSA's and other infections give the technology most testing data and additionally publication materials and exposures to infectious disease physicians, pathologists and molecular laboratory directors...
The patterns of large run ups and retreats is astounding... this is the result of being a development stage company with limited revenues and a moderately long horizon for diagnostic technology to reach marketability...
This accelerated diagnostic tool is a "razor and razor blade product model"... device may sale for $50K... the specimen cartridges may sale for $150... every hospital with an ICU, CCU and Surgical center will likely buy the device for better patient outcomes for hospital related infections which are one of the highest mortalities in US hospitals... and obviously large cost due to lawsuits... so every Hospital Board (risk management) will want to spend the cost to have this accelerated diagnostic tool in their facilities...
Another important factor to monitor in 2014... AXDX was added to Russell 2000 index in June 2013 and subsequently market value exceeded $1B and was removed as of June 2014... it is highly likely that as of June 2014 AXDX will still be under $1B market value... and will be re-added to Russell 2000 index... this creates demand for shares as the Russell 2000 index through funds that access this index account for Trillions of dollars of assets...
As you see AXDX is in retreat... which is consistent with prior pattern actions... I start tracking closely in the 16s... I start buying in the 15s... it could go lower if the general market conditions go south... regardless... it has popped to over 30s twice in 2014... this stock loves Octobers... look at patterns over past three years...
This is a nice stock to buy low and sale high... and repeat... I gain lots of comfort from the fact that once the accelerated diagnostic tool achieves marketability... the North American Market for this product is over $1B for the device... more for the ongoing specimen cartridges annuity stream... the International Market for this product is over $1.5B... that is a healthy market to start selling to...
I believe the target PPS for 2nd Quarter 2016 might be conservatively $40 to $60 PPS... so this is a great LONG buy and HOLD stock as well...
Great management team that has been successful repeatedly in this sector with other companies such as Ventana and Stericycle... do some diligence and take a chance...
GOOD LUCK TO ALL IN 2015!!!
Thanks, lodo, I concur based on my experience with this stock. Have you been in in touch with the company or any prior management to verify that things are on track for the time frame that you lay out?
AXDX - All we are starting the last stage of the downward push on the PPS... typically I start looking to buy in in stages under $16 PPS... with concentration once it goes into the mid $15 PPS range... that said if general market conditions (S&P go down) track downward this could go lower... what is consistent is the up ticks... which are fast and powerful... in the past six month we have seen two trips from sub $16 PPS to over $30 PPS... and we are still 16 months from monetization of the diagnostic tool (think April 2016)... what has occurred - in June AXDX was removed from Russell 2000 and we suddenly peaked over $30... the sell off from index funds dropped the price back down toward $16 PPS in July... then "maybe" an ebola event and some news related to CDC collaboration drove PPS back up over $30 again in October (this stock loves Octobers)... and now we find ourselves getting near $18 PPS as we track down toward an intra-peak low... get ready for a buy in point staged after we go below $16 PPS and move toward $15 PPS (maybe lower if market suddenly goes south)... we should see a mid year peak above $30 PPS again in 2015... or hold this stock long... as the mid 2016 PPS should be between $40 to $60 PPS range... good hunting...
AXDX - I buy in at points below $16 PPS... then ride the oversold and short covering momentum up to over $30 PPS... pretty consistent roller coaster ride until revenues hit in 2016... JMHO
$AXDX DD Notes ~ http://www.ddnotesmaker.com/AXDX
bullish very long term
$AXDX recent news/filings
## source: finance.yahoo.com
Mon, 27 Oct 2014 22:06:29 GMT ~ Nasdaq stocks posting largest percentage decreases
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220242625--finance.html
*********************************************************
Tue, 14 Oct 2014 16:15:35 GMT ~ Accelerate Diagnostics: Mistakenly Rewarded and Vulnerable to a Brutal Correction
read full: http://finance.yahoo.com/tumblr/blog-accelerate-diagnostics-mistakenly-rewarded-and-161538949.html
*********************************************************
Thu, 25 Sep 2014 18:35:25 GMT ~ Accelerate Diagnostics Supports Drug Stewardship and Early Detection in the President's Initiative to Combat Antibiotic-Resistant Bacteria
[GlobeNewswire] - TUCSON, Ariz. -- Accelerate Diagnostics, Inc. , an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant organisms, today commended the Obama Administration's ...
read full: http://finance.yahoo.com/news/accelerate-diagnostics-supports-drug-stewardship-183525386.html
*********************************************************
Fri, 08 Aug 2014 17:04:19 GMT ~ ACCELERATE DIAGNOSTICS, INC Financials
read full: http://finance.yahoo.com/q/is?s=axdx
*********************************************************
Fri, 01 Aug 2014 15:32:12 GMT ~ ACCELERATE DIAGNOSTICS, INC Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/140801/axdx10-q.html
*********************************************************
$AXDX charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AXDX company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AXDX/company-info
Ticker: $AXDX
OTC Market Place: Not Available
CIK code: 0000727207
Company name: Accelerate Diagnostics, Inc.
Company website: http://www.accelr8.com
Incorporated In: CO, USA
$AXDX share structure
## source: otcmarkets.com
Market Value: $1,006,686,217 a/o Oct 27, 2014
Shares Outstanding: 44,583,092 a/o Jul 28, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$AXDX extra dd links
Company name: Accelerate Diagnostics, Inc.
Company website: http://www.accelr8.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AXDX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AXDX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AXDX+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AXDX/news - http://finance.yahoo.com/q/h?s=AXDX+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AXDX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AXDX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AXDX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AXDX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Accelerate+Diagnostics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Accelerate+Diagnostics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Accelerate+Diagnostics%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.accelr8.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.accelr8.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.accelr8.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AXDX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000727207&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AXDX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AXDX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AXDX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AXDX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AXDX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AXDX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AXDX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AXDX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AXDX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AXDX+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AXDX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AXDX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AXDX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AXDX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AXDX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AXDX/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AXDX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AXDX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AXDX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AXDX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AXDX
$AXDX DD Notes ~ http://www.ddnotesmaker.com/AXDX
AXDX... love this company... but there won't be much to keep the price up... and SHORT there will be a lot of SHORT positions put in place again... so the PPS will have a pretty quick run down once it starts... I noticed that from July 31st to September 15th over 1M new SHORT interest were placed on this issue...
Hope you made some nice money on this October run up!...
I will be buying back in around $15-16.50 range... maybe lower if there is a general decline in market... in Nov-Jan...
Good Hunting...
It appears to me, from talking with people familiar with short selling, that this run up is due to short covering. I am not very familiar with short selling so I don't understand your statement that "shorts are loading up". Does that mean they are getting ready to sell shares they don't have? Again? You would think that they have been burned enough.
AXDX - Here was the October "run up" I promised... figure out your exit point... take your gains and sell... the SHORTS have loaded up on shares and will start their magic soon enough... this could have a steep and deep "run down"... the stock feels more comfortable below 17.50... remember AXDX needs to be below the $1B market cap for inclusion to the Russell 2000 index at the selection point... and the company is still 18 months (March / April 2016) away from the last permanent "run up" when their product reaches market and they have revenues... in the mean time... let's enjoy the cycles and know that even if you miss... this issue is a great LONG hold for your portfolio...
I love your comments. So, I needn't be too sorry I didn't bail out after the last run up to $30.00. I, too am expecting much higher prices from here, it is nice to have confirmation of another opinion.
Thank you!
AXDX - I have been invested in this stock since 2008... there is typically a significant uptick as we head into Q4... also typically momentum down is never longer than 30 to 45 days... we should be hitting that range soon... lastly MACD below the line is approaching the length where it will move up... this stock does nothing smoothly... its ups are fast and sharp... as are its downs... additionally insider buying is on the up tick... and they are smart buyers and have a habit of buying at low points followed by sharp upticks... lastly the SHORTS love this stock and they need a nice run up to start their game again...
BTW this is a nice short term stock to game... but is a no lose... this stock will reach 40-50s when the game changing diagnostic equipment reaches market in early 2016... ENJOY!!
What do you mean; how do you come to this conclusion?
AXDX - It seems like I am the only one on this board... but I believe we might be getting within 30 days of one of this particular stocks routine 33% run-up on PPS... JMHO
SHORT Sellers are pushing AXDX lower again... might be a good entry point for another short up run...
Apparently not! The intraday low on Monday, August 5th was 15.37! Can it still go lower. This intraday low is 50% off the recent high of over $30/share.
any dedicated to providing solutions for the global challenge of drug resistant organisms and hospital acquired infections, announced today that it has commenced a $45,000,000 rights offering to fund its product commercialization efforts.
Under the terms of the rights offering, the company is distributing, at no charge to the holders of its common stock as of 5:00 p.m., New York City time, on March 14, 2014, which was established as the record date for the rights offering, 0.063921 non-transferable subscription rights for each share of common stock owned on the record date, as more fully described in the prospectus relating to the rights offering. Each whole subscription right will allow the holder to subscribe to purchase one share of common stock at a subscription price of $16.80 per share. In the aggregate, the company intends to issue 2,678,571 shares of common stock in connection with the rights offering.
The subscription rights may be exercised until 5:00 p.m. New York City time, on April 28, 2014, as more fully described in the prospectus. The rights offering period may not be extended. Any fractional rights remaining after aggregating all of the subscription rights issued to a stockholder will be rounded down to the nearest whole number, and no stockholder will receive any shares with respect to fractional rights that are rounded down.
The company has received a standby commitment from the Jack W. Schuler Living Trust and the Schuler Family Foundation. The standby purchaser has agreed to purchase any and all shares of common stock that are not subscribed for by stockholders in connection with the rights offering. Upon completion of the rights offering, the company will receive gross proceeds of approximately $45,000,000 before expenses. The purpose of the rights offering is to raise equity capital in a cost-effective manner that gives all of the company's existing stockholders the opportunity to participate on a pro rata basis. The net proceeds of the offering will be used for working capital and specifically to fund the company's business plan and product commercialization efforts.
A Registration Statement relating to these securities has been filed with the SEC and was declared effective on April 7, 2014. A copy of the prospectus forming a part of the Registration Statement may be obtained free of charge at the website maintained by the SEC at www.sec.gov or by contacting Steve Reichling at (520) 365-3100. For questions about the rights offering, including questions about subscription procedures and requests for additional copies of the prospectus, contact Broadridge Corporate Issuer Solutions, Inc. at (855) 793-5068. Broadridge is acting as the Subscription and Information Agent for the rights offering on behalf of the company.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
- See more at: http://www.noodls.com/view/A68E76F6CBC5AB286AF6AA42E60360ACE2B3F55D?8327xxx1396899372#sthash.leyT5F9S.dpuf
Thanks! Bought in at $8.38 and have ridden up and down with this one. Low volume, big swings, I have never seen anything like this!
Followers
|
8
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
72
|
Created
|
01/01/14
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |